SEGLUROMET is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Ertugliflozin Pidolate; Metformin Hydrochloride.
| Product ID | 50090-6218_63ca4364-3620-402e-accc-1c231ac85173 |
| NDC | 50090-6218 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SEGLUROMET |
| Generic Name | Ertugliflozin And Metformin Hydrochloride |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-12-19 |
| Marketing Category | NDA / |
| Application Number | NDA209806 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | ERTUGLIFLOZIN PIDOLATE; METFORMIN HYDROCHLORIDE |
| Active Ingredient Strength | 3 mg/1; mg/1 |
| Pharm Classes | Biguanide [EPC], Biguanides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-11-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-5369 | SEGLUROMET | ertugliflozin and metformin hydrochloride |
| 0006-5370 | SEGLUROMET | ertugliflozin and metformin hydrochloride |
| 0006-5373 | SEGLUROMET | ertugliflozin and metformin hydrochloride |
| 0006-5374 | SEGLUROMET | ertugliflozin and metformin hydrochloride |
| 50090-6217 | SEGLUROMET | ertugliflozin and metformin hydrochloride |
| 50090-6218 | SEGLUROMET | ertugliflozin and metformin hydrochloride |
| 50090-6231 | SEGLUROMET | ertugliflozin and metformin hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SEGLUROMET 86727956 5570929 Live/Registered |
Merck Sharp & Dohme Corp. 2015-08-18 |